Skip to content

Effect of Treatment of Temporomandibular Joint in Patients With Chronic Migraine and Temporomandibular Disorders

Effect of Treatment of Temporomandibular Joint in Patients With Chronic Migraine and Temporomandibular Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02627014
Enrollment
45
Registered
2015-12-10
Start date
2015-07-31
Completion date
2017-03-31
Last updated
2017-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Migraine, Temporomandibular Disorders

Keywords

Chronic Migraine, Temporomandibular Disorders, Physical Therapy, Manual Therapy, Home physical Therapy

Brief summary

The aim of this study is to determine whether treatment of temporomandibular joint is more effective than usual care in patients with chronic migraine and temporomandibular disorders to reduce pain.

Detailed description

The aim of this study is to determine whether treatment of temporomandibular joint added to the control group treatment and drug therapy patient base is more effective than just using the control group treatment and drug therapy in patients with chronic migraine and temporomandibular disorders to reduce pain and improve the quality of life related to health of patients.

Interventions

OTHERManual therapy

6 treatments: 2 treatments for week 1 treatment = 30 minutes

once a day: 15 minutes

OTHERManual therapy in cervical region

6 treatments: 2 treatments for week 1 treatment = 30 minutes

OTHERHome physical therapy in cervical region

once a day: 15 minutes

Sponsors

Hospital Miguel Servet
CollaboratorOTHER
Cardenal Herrera University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Chronic migraine (ICHD\_III beta, 2013) * Temporomandibular disorders (RDC/TMD)

Exclusion criteria

* other neurological disease * psychiatric diseases * Physical therapy treatment in the last 6 months * dental treatment in the last 6 months * surgery or trauma in the orofacial region

Design outcomes

Primary

MeasureTime frame
Headache Impact Test (HIT-6)3 months

Secondary

MeasureTime frameDescription
Quality of life (SF-36)3 months
Sleep Quality3 monthsPittsburgh Sleep Quality Index
Pain threshold pressure3 monthsPressure algometer in masticatory muscle (area trigeminal) and control point in area extra-trigeminal
Pain catastrophizing scale (PCS)3 months
Visual Analogue Scale (VAS)3 months
Tampa scale of Kinesiophobia (TSK)3 months
Tampa scale of Kinesiophobia of cranio-mandibular disorder (TSK-TCM)3 months
Maximal Mouth Opening pain free3 months
Craniofacial Pain and Disability Inventory (CF-PDI)3 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026